VitaSignal offerings
Explore Clinical AI Buyer Readiness, Institutional Feasibility Review and Governance Evaluation. They have separate scopes and are not a required sequence. This is the company information website, not another assessment app. This page does not qualify a real tool, generate a readiness score or authorize clinical use.
Explore the synthetic demonstrationOffering guide
Vendor preparation, institutional feasibility and governance evaluation address different needs. Each has its own scope and intended deliverable. They are optional purchases, not a required sequence.
Buyer Readiness is in private preview. Institutional engagements require an agreed scope, delivery capacity and separate authorization. Tools remain in development and are not for clinical use.
For clinical AI and digital health vendors
Private preview
Vendor-facing software intended to organize a product's intended use, claims, supporting sources, limitations and unresolved questions into a versioned Buyer Readiness Record.
A prepared record is not independent validation, institutional approval or evidence of local suitability.
Explore Buyer ReadinessAsk about a guided walkthroughFor healthcare institutions and evaluation teams
Scope discussion
Define the workflow, data-pathway questions, approval needs and unresolved evidence for one institutional use case. The proposed deliverable is an institution-specific feasibility assessment with scoped next steps.
A starting review may use approved nonpatient documents and stakeholder conversations. Scope, handling terms, capacity and price must be agreed before work starts.
Individually scoped institutional work
Discuss a feasibility reviewFor institutions authorizing a defined evaluation
Separate authorization
A separately scoped evaluation intended to document evidence, limitations, risks and recommendations in a Governance Decision Package for a defined local use.
Qualified reviewers, an agreed protocol and applicable approvals are required. Findings may be blocked or inconclusive, or recommend pausing or stopping. The institution retains decision authority.
No clinical-use or deployment authority
Discuss an evaluationA vendor record does not require or guarantee an institutional engagement or a favorable finding. Preparing a vendor's material also does not establish independence for a later evaluation of that product.
VitaSignal's existing EHR and Data Pathway prototype is supporting infrastructure for institutional reviews. Its working application name is VitaSignal EHR Data & AI Evaluation Readiness.
The intended functions cover use-case setup, authorized read-only data pathways, field availability, data quality, provenance, reviewer controls and a versioned EHR Data Readiness Summary. Documentation-pattern review belongs only where the use case and approved information justify it.
The app remains a private prototype. No production connector, completed local integration, security acceptance or clinical deployment is represented.
Explore the data-readiness approachApp access, data permissions and any handoff require their own authorization. Shared sign-in, automatic record transfer and a connected product workflow are not established.
Use the existing contact form for a nonconfidential conversation about vendor evidence, institutional feasibility or a separately authorized evaluation. An inquiry does not create a product account, submit a tool for assessment, promise a deliverable or establish a partnership. Any later evaluation requires a separately agreed scope and the necessary approvals.
Request a scope discussionDo not send PHI, patient-level data, confidential vendor files or credentials.
